Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
Syneos Health (Nasdaq:SYNH) has announced the release of its first quarter 2023 financial results, scheduled for May 10, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Syneos Health (Nasdaq:SYNH) has announced the release of its first quarter 2023 financial results, scheduled for May 10, 2023. The earnings call will commence at 8:00 a.m. ET, and interested investors can access the live webcast through the Investor Relations section of their website.
Participants are required to register in advance to receive a confirmation email with dial-in instructions and a unique passcode. A replay of the webcast will be accessible on the website after 1:00 p.m. ET on the same day.
Syneos Health is recognized as a leading fully integrated biopharmaceutical solutions organization, focusing on translating clinical and commercial insights into improved patient outcomes across over 110 countries.
Details
News Market Reaction – SYNH
The recorded move for SYNH in the trading session of this news was -2.02%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial results on Wednesday, May 10th, 2023, prior to its earnings call at 8:00 a.m. ET.
To listen only and view the presentation slides via the live webcast, join from the Investor Relations section of the Syneos Health website at investor.syneoshealth.com.
To participate in the conference, please register in advance at this link. Upon registration, all participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on May 10th, 2023.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
| Investor Relations Contact: | Press/Media Contact: |
| Ronnie Speight | Gary Gatyas |
| Senior Vice President, Investor Relations | Executive Director, External Communications |
| +1 919 745 2745 | +1 908 763 3428 |
| Investor.Relations@syneoshealth.com | gary.gatyas@syneoshealth.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.